339 related articles for article (PubMed ID: 15373067)
21. [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
Warpakowski A
MMW Fortschr Med; 2009 Apr; 151(18):54-5. PubMed ID: 19769077
[No Abstract] [Full Text] [Related]
22. Safety and efficacy of regimens containing emtricitabine in HIV-infected patients taking highly active antiretroviral therapy.
Marconi P; Lorenzini P; Borrelli I; Liuzzi G; Sette P; Zaccarelli M; Antinori A
New Microbiol; 2006 Jul; 29(3):169-75. PubMed ID: 17058783
[TBL] [Abstract][Full Text] [Related]
23. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
[No Abstract] [Full Text] [Related]
24. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
Wepner U
MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
[No Abstract] [Full Text] [Related]
25. Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor.
Modrzejewski KA; Herman RA
Ann Pharmacother; 2004 Jun; 38(6):1006-14. PubMed ID: 15121999
[TBL] [Abstract][Full Text] [Related]
26. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
Sarfo FS; Bibby DF; Schwab U; Appiah LT; Clark DA; Collini P; Phillips R; Green I; Dittmar MT; Chadwick DR
J Antimicrob Chemother; 2009 Sep; 64(3):667-9. PubMed ID: 19549668
[No Abstract] [Full Text] [Related]
27. Summaries for patients. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and patient outcomes.
Ann Intern Med; 2007 Apr; 146(8):I28. PubMed ID: 17438312
[No Abstract] [Full Text] [Related]
28. New drugs.
Pozniak A
J HIV Ther; 2008 Jun; 13(2):27-33. PubMed ID: 18953271
[No Abstract] [Full Text] [Related]
29. The clinical significance of viral fitness.
Geretti AM
J HIV Ther; 2005 Mar; 10(1):6-10. PubMed ID: 15951728
[TBL] [Abstract][Full Text] [Related]
30. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Otto MJ
Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
[TBL] [Abstract][Full Text] [Related]
31. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
[No Abstract] [Full Text] [Related]
32. 144-week data released on Gilead's study 934.
AIDS Patient Care STDS; 2007 Aug; 21(8):603-4. PubMed ID: 17902243
[No Abstract] [Full Text] [Related]
33. HIV-1 reverse transcriptase inhibitors.
El Safadi Y; Vivet-Boudou V; Marquet R
Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
[TBL] [Abstract][Full Text] [Related]
34. The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine.
Sproat M; Pozniak AL; Peeters M; Winters B; Hoetelmans R; Graham NM; Gazzard BG
Antivir Ther; 2005; 10(2):357-61. PubMed ID: 15865231
[TBL] [Abstract][Full Text] [Related]
35. [First line therapy. Tenofovir DF/emtricitabine--the potent backbone].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():12-4. PubMed ID: 19024908
[No Abstract] [Full Text] [Related]
36. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
Kravchenko AV
Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
[No Abstract] [Full Text] [Related]
37. Revisiting the concept of a genetic barrier to resistance.
Rusconi S
J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
[No Abstract] [Full Text] [Related]
38. [Simply convincing. New fixed combination for HIV therapy].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
[No Abstract] [Full Text] [Related]
39. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
[No Abstract] [Full Text] [Related]
40. Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
Williams I
J HIV Ther; 2008 Mar; 13(1):19-23. PubMed ID: 18953269
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
